New 'unified theory' of childhood leukemia raises possibility of preventing the disease

May 28, 2018 by Melissa Healy, Los Angeles Times

Kids who develop acute lymphoblastic leukemia may be the victims of a triple-whammy stroke of bad luck, according to a provocative new theory from a respected British cancer researcher.

If the explanation turns out to be correct, it would be good news for the most common type of childhood cancer: Doctors could prevent cases of acute lymphoblastic with the strategic introduction of something the world has plenty of: filth and pestilence.

Melvin Greaves, a cell biologist who directs the Center for Evolution and Cancer at the Institute of Cancer Research in London, has been trying to unravel the causes of for 30 years. His "unified theory" of leukemia, which draws upon research from genetics, immunology, microbiology, epidemiology and evolution, is laid out this week in the journal Nature Reviews Cancer.

Greaves' treatise is a kind of scientific stem-winder that posits that modern humans, in our admirable zeal to prevent infectious diseases and spruce up the environs in which we raise our young, have inadvertently broken a rule imposed by millions of years of co-evolution with our microbe-filled environment.

That rule, repeated by grandmothers everywhere, tells us that, in life, we must "eat a peck of dirt."

In the industrialized world, roughly 1 in 2,000 children will develop acute lymphoblastic leukemia before the age of 15. Their bone marrow cells grow and divide rapidly, resulting in too many immature cells that interfere with the normal production of blood cells. Thanks to improved treatments, 90 percent of patients will survive, albeit with persistent health problems and an early burden of existential dread.

Acute lymphoblastic leukemia is on the rise throughout the industrialized world. In the United States and Europe, the incidence is increasing by 1 percent a year. In search of an explanation, researchers have explored a long list of modern enviromental influences, including ionizing radiation, electricity cables, electromagnetic waves and man-made chemicals.

That research just doesn't add up, Greaves argues.

Instead, he makes the case that three steps, performed in just the right order, set the stage for acute lymphoblastic leukemia.

First, a baby is born with a random transcription error in her genes. It's a mutation so common—in twin studies, Greaves and his colleagues have discovered that 1 in 20 children are born with it—that it might never have drawn the suspicion of researchers.

The mutation results in a fusion gene called ETV6–RUNX1. But if 1 in 20 are born with it and only 1 in 2,000 end up with acute lymphoblastic leukemia, some trigger is clearly necessary for the disease to progress.

That trigger, argues Greaves, is actually something that doesn't happen. It must be a combination of events that generally happens in early childhood, and that would prime the immune system to block leukemia. Left unprimed, the immune system is left vulnerable to step three.

Finally, at some key point before the age 20 (when nature appears to wipe the mutation clean), a seemingly minor infection must happen. It could be something as insignificant as a touch of flu.

This final blow may prompt a further genetic mutation, activating the malignant potential of these first two factors and igniting a process in which the bone marrow's production of immature lymphocytes spins out of control.

Greaves' "delayed infection" theory suggests that when it comes to teaching the immune system about infectious threats, the sooner the better. In the absence of early priming (and in the presence of the right genetic mutation), a later infection can trigger leukemia.

As support for the role of steps two and three, Greaves cited epidemiological studies that have found the incidence of acute lymphoblastic leukemia is notably higher in children who did not attend day care, were firstborn in their families, were not breastfed, and were born via caesarian section rather than vaginally. All of those, he said, are fair surrogates for lower levels of early-life exposure to germs and infections.

He then dissected a number of recorded clusters of acute lymphoblastic leukemia to find common threads. In one cluster, seven children in Milan, Italy, were diagnosed with the cancer in a four-week period. Greaves' sleuthing turned up evidence that all seven patients had been infected in a swine flu outbreak three to six months prior to their diagnosis. Six of the seven patients were firstborn children, and none attended day care in the first year of life.

Finally, in mice engineered to have the high levels of the protein that allows acute lymphoblastic leukemia to gain a foothold, Greaves and his colleagues found one highly reliable way to induce leukemia: by moving the mice from germ-free housing to cages teaming with microbial life after their early childhood.

Paul Workman, the chief of London's Institute of Cancer Research, said Greaves' work suggested that most cases of childhood leukemia were likely to be preventable.

"It might be done in the same way that is currently under consideration for autoimmune disease or allergies—perhaps with simple and safe interventions to expose infants to a variety of common and harmless bugs," he said.

Dr. Bert Vogelstein, a Johns Hopkins University geneticist whose research has helped tease out the role of random mutations in cancer, said that scientists have already come to appreciate that two genetic alterations are likely required for to develop.

That the catalyzing alteration is the result of a bout of infectious illness "is a reasonable and intriguing hypothesis," said Vogelstein, who called the new hypothesis "stimulating." But "it is still speculative and much more research must be done to confirm or refute it," he said.

Explore further: Scientists reveal likely cause of childhood leukaemia

More information: A causal mechanism for childhood acute lymphoblastic leukaemia, Nature Reviews Cancer (2018) DOI: 10.1038/s41568-018-0015-6 ,

Related Stories

Scientists reveal likely cause of childhood leukaemia

May 21, 2018
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, following more than a century of controversy about its origins.

Two genes cooperate to trigger leukemia development

March 20, 2018
An international group of researchers led by Prof. Jan Cools of the VIB-KU Leuven Center for Cancer Biology have made a breakthrough in understanding the development of acute lymphoblastic leukemia, an aggressive cancer of ...

Blincyto approval expanded for specific leukemia

March 30, 2018
(HealthDay)—The U.S. Food and Drug Administration says it has expanded approval for Blincyto (blinatumomab) to include adults and children with B-cell precursor acute lymphoblastic leukemia who are in remission but who ...

Scientists propose solution for blast cells' classification in diagnostics of acute lymphoblastic leukemia

September 19, 2016
Currently, diagnostics of acute leukemia are based on manual calculations of different types of cells by blood smears and bone marrow aspirations. The data from morphological research conducted by doctors in the microscopic ...

New CAR T case study shows promise in acute myeloid leukemia

May 9, 2018
Chimeric Antigen Receptor T-cell therapy, also known as CAR T therapy, was named the biggest research breakthrough of 2017 by the American Society of Clinical Oncology. The personal gene therapy utilizes a patient's own immune ...

Findings pave way for three-drug combination treatment for childhood leukemia

August 15, 2017
UCLA researchers have developed a new approach that could eventually help young people respond better to treatment for acute lymphoblastic leukemia. The scientists discovered in mice that when the production of nucleotides—also ...

Recommended for you

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.